Stock Performance – Talk Bio

Actionable Insights Powered by AI

4DMT’s Wet AMD Gene Therapy Results Disappoint Investors, Stock Plummets

11 months ago talkbio0Tagged Clinical Trials, gene therapy, Glycogen storage disease type II, Stock Performance

4DMT, Wet AMD, Gene Therapy, Stock Performance, Clinical Trials